Evidence map›Paper›PMID 38269632›Full record

SynthesisClinical cardiology2024

Effects of flaxseed supplementation on weight loss, lipid profiles, glucose, and high-sensitivity C-reactive protein in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.

Hamid Reza Sabet, Mohammad Ahmadi, Mehdi Akrami, Mahsa Motamed, Omid Keshavarzian, Mozhan Abdollahi, Mehdi Rezaei, Hamed Akbari

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Impact of Dietary Fiber on Inflammation in Humans.International journal of molecular sciences · 2025
    Review
  8. Anti-Oxidant and Anti-Cancer Properties of Flaxseed.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hamid Reza SabetMedical Journalism Department, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad AhmadiStudents' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-5788-0788
Mehdi AkramiCardiovascular Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Mahsa MotamedDepartment of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.
Omid KeshavarzianShiraz School for Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mozhan AbdollahiStudent Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mehdi RezaeiDepartment of Cardiology, Fars-Iranian Heart Association, Fars Society of Internal Medicine, Shiraz, Iran.ORCID http://orcid.org/0000-0001-8127-4764
Hamed AkbariDepartment of Clinical Biochemistry, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.ORCID http://orcid.org/0000-0002-9939-6652
Shiraz University of Medical Sciences · IRTehran University of Medical Sciences · IRKerman University of Medical Sciences · IRRegional Information Center for Science and Technology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This meta-analysis aimed to evaluate the effects of flaxseed supplementation on weight loss, lipid profiles, high-sensitivity C-reactive protein (hs-CRP), and glucose levels in patients with coronary artery disease (CAD). A systematic search was performed using various online databases, including Scopus, PubMed, Web of Science, EMBASE, and Cochrane Library, to identify relevant randomized controlled trials (RCTs) until June 2023. To evaluate heterogeneity among the selected studies, the Q-test and I

Indexed as

Coronary Artery DiseaseFlaxCholesterol, HDLC-Reactive ProteinDietary SupplementsGlucoseHumansRandomized Controlled Trials as TopicWeight LossCholesterol, HDLC-Reactive ProteinGlucoseanthropometric indicescoronary artery diseasesflaxseedglucoseinflammationlipidmeta-analysis

Identifiers

PMID38269632
PMCPMC10790321
OpenAlexW4390920815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.